Breaking
Desogestrel contraceptives: 1.6 million women warned of tumour risk
On 2026-09-10, France's medicines agency ANSM issued a warning to 1.6 million women using desogestrel-based contraceptives about a potential risk of developing tumours. The agency advised women to consult a doctor if they experience symptoms such as persistent headaches, visual disturbances, or memory loss. ANSM emphasized the importance of medical consultation for those affected, but did not specify the exact nature or frequency of the tumour risk. The warning aims to ensure early detection and appropriate care.
Ozetta vat samen; de journalistiek is van de redactie